CH620203A5 - - Google Patents

Download PDF

Info

Publication number
CH620203A5
CH620203A5 CH589877A CH589877A CH620203A5 CH 620203 A5 CH620203 A5 CH 620203A5 CH 589877 A CH589877 A CH 589877A CH 589877 A CH589877 A CH 589877A CH 620203 A5 CH620203 A5 CH 620203A5
Authority
CH
Switzerland
Prior art keywords
formula
ethanol
lower alkyl
imidazoline
compound
Prior art date
Application number
CH589877A
Other languages
English (en)
French (fr)
Inventor
Graham John Durant
Charon Robin Ganellin
Margaret Rose Vickers
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of CH620203A5 publication Critical patent/CH620203A5/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/32Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH589877A 1976-05-14 1977-05-11 CH620203A5 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB19994/76A GB1592453A (en) 1976-05-14 1976-05-14 Aminoalkyl esters of carbarimidothioic acid and compositions having immunosuppressant activity

Publications (1)

Publication Number Publication Date
CH620203A5 true CH620203A5 (da) 1980-11-14

Family

ID=10138568

Family Applications (1)

Application Number Title Priority Date Filing Date
CH589877A CH620203A5 (da) 1976-05-14 1977-05-11

Country Status (23)

Country Link
US (1) US4294854A (da)
JP (1) JPS532420A (da)
AR (1) AR218872A1 (da)
AT (1) AT359521B (da)
AU (1) AU509573B2 (da)
BE (1) BE854553A (da)
CA (1) CA1086758A (da)
CH (1) CH620203A5 (da)
DE (1) DE2721830A1 (da)
DK (1) DK211277A (da)
ES (1) ES458756A1 (da)
FI (1) FI771400A (da)
FR (2) FR2351098A1 (da)
GB (1) GB1592453A (da)
HU (1) HU174978B (da)
IE (1) IE45144B1 (da)
IL (1) IL52011A (da)
LU (1) LU77332A1 (da)
NL (1) NL7705331A (da)
NO (1) NO771697L (da)
PT (1) PT66509B (da)
SE (1) SE7705658L (da)
ZA (1) ZA772612B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0672244B2 (ja) * 1984-12-12 1994-09-14 三菱マテリアル株式会社 貴金属造粒装置
AU695120B2 (en) * 1993-06-07 1998-08-06 Baylor College Of Medicine Use of an MHC class I suppressor drug for the treatment of autoimmune diseases and transplantation rejection
AU3230895A (en) * 1994-08-18 1996-03-14 Chugai Seiyaku Kabushiki Kaisha Amino acid derivative having nitrogen monoxide synthetase inhibitor activity
US7645873B2 (en) * 2003-03-20 2010-01-12 The Scripps Research Institute 6″-amino-6″-deoxygalactosylceramides
EP2058011A1 (en) * 2007-11-07 2009-05-13 Wittycell Nkt cell activating gycolipids covalently bound antigens and/or drug
US9220767B2 (en) * 2008-10-08 2015-12-29 Abivax Vaccine composition for use against influenza

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2648710A (en) * 1950-09-22 1953-08-11 Hoffmann La Roche Bis-quaternary salts of 1:10-bis-(dialkylamino)-5:6-dithia-decane
US2813102A (en) * 1956-04-10 1957-11-12 American Home Prod 2-(di-lower alkylaminoethylmercapto)-imidazolines and their acid addition salts and preparation thereof
US4152453A (en) * 1975-12-01 1979-05-01 Smith Kline & French Laboratories Limited Pharmacologically active compounds and compositions and methods of use

Also Published As

Publication number Publication date
FR2351098A1 (fr) 1977-12-09
US4294854A (en) 1981-10-13
AU509573B2 (en) 1980-05-15
ATA318277A (de) 1980-04-15
FR2472935A1 (fr) 1981-07-10
IE45144L (en) 1977-11-14
ZA772612B (en) 1978-04-26
DK211277A (da) 1977-11-15
BE854553A (fr) 1977-11-14
IL52011A (en) 1982-05-31
ES458756A1 (es) 1978-03-01
CA1086758A (en) 1980-09-30
AR218872A1 (es) 1980-07-15
PT66509B (en) 1978-10-16
DE2721830A1 (de) 1977-11-24
FR2351098B1 (da) 1982-06-18
LU77332A1 (da) 1977-08-29
NL7705331A (nl) 1977-11-16
PT66509A (en) 1977-06-01
SE7705658L (sv) 1977-11-15
HU174978B (hu) 1980-04-28
JPS532420A (en) 1978-01-11
NO771697L (no) 1977-11-15
GB1592453A (en) 1981-07-08
FI771400A (da) 1977-11-15
AT359521B (de) 1980-11-10
IE45144B1 (en) 1982-06-30
AU2507977A (en) 1978-11-16

Similar Documents

Publication Publication Date Title
EP0001727B1 (fr) Nouveaux dérivés du phényl-4-(trichloro-2',2',2'-éthoxycarboxamido)-2-thiazole utiles comme médicaments, compositions pharmaceutiques les contenant et leur procédé de préparation
EP0556080B1 (fr) Dérivés bicycliques de la pyridine, leur procédé de préparation, les intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
CA1209571A (en) Crystalline benzothiazine dioxide salts
EP0227539B1 (fr) Nouvelles 4H-triazolo /4,3-a/ /1,4/ benzodiazépines, leur procédé de préparation leur application comme médicaments et les compositions les renfermant
FR2510998A1 (fr) Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
EP0217700A1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
EP0116494B1 (fr) Dérivés de la pyridazine ayant une action psychotrope, procédé d'obtention, intermédiaires et médicaments en contenant
JPS62294674A (ja) 1,4−二置換ピペラジン誘導体、これを含む薬用組成物並びにその製造方法
EP0000299B1 (fr) Nouveaux dérivés de benzoyl-2-chloro-4-glycinanilides substitués, leur procédé de préparation et leur application en tant que médicaments.
EP0377528A1 (fr) Pipéridines, procédés de préparation et médicaments les contenant
FR2548666A1 (fr) Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
EP0239461A1 (fr) Dérivés de N-¬¬(hydroxy-2 phényl) (phényl) méthylène amino-2 éthyl acétamide, leur préparation et leur application en thérapeutique
EP0076199B1 (fr) Nouvelles triazoloquinazolones et leurs sels, procédé et intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
CH620203A5 (da)
JPH0641465B2 (ja) ベンゾチアジンジオキシド誘導体
EP0114770A2 (fr) Composés à noyau hétérocyclique diazoté, leur procédé de préparation et les médicaments, actifs sur le système nerveux central, qui en contiennent
CA1082716A (fr) Procede de preparation de nouveaux derives de 5- thiazole methane amine
EP0153230A2 (fr) Nouveaux dérivés du pyrimido /2,1-b/ benzothiazole et leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant
EP0304353A1 (fr) Dérivés de benzimidazole et leur préparation
FR2521144A1 (fr) Nouveaux derives de la piperazinyl-2 phenyl-4 quinazoline possedant des proprietes antidepressives, methode de preparation desdits composes et medicaments en contenant
EP0176444B1 (fr) Nouveau procédé de préparation de dérivés du 4 H-1,2-4-triazole, nouveaux triazoles ainsi obtenus, leur applicication comme médicaments et les compositions pharmaceutiques les renfermant
EP0003920B1 (fr) Thiéno (3,2-c) et thiéno (2,3-c)pyridines, leur procédé de préparation et leur application en thérapeutique
FR2615188A1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
LU86226A1 (fr) Nouvelles 8-acylaminoergolines,leur preparation,leur utilisation comme medicaments et les compositions pharmaceutiques les contenant
EP0010030B1 (fr) Nouveaux dérivés d'ortho chloro benzoyl-2 chloro-4 glycylanilide, leur préparation et leur application en tant que médicaments

Legal Events

Date Code Title Description
PL Patent ceased